Skip to main content
Premium Trial:

Request an Annual Quote

Children's Hospital Boston to Use Febit Geniom RT Analyzer for Targeted Resequencing

Premium

This article was originally published Jan. 21.

Febit said last week that the molecular genetics core facility at Children's Hospital Boston will use its Geniom RT Analyzer for targeted resequencing with the company's HybSelect technology.

The core facility, which is scheduled to receive the instrument later this month, plans to use the HybSelect technology in conjunction with its Applied Biosystems SOLiD platform.

"The ease and flexibility of HybSelect allows us to study a variety of genetic diseases and multiplex bar-coded libraries, making sequence-capture projects much more accessible and affordable to our investigators," said Hal Schneider, manager of the facility, in a statement issued by Febit.

Febit CSO Peer Stähler said that the company is working on a set of 96 barcodes for HybSelect, which will enable scientists to sequence up to 2,304 samples in six days.

Last year, the firm struck a co-marketing agreement with Life Technologies and installed two SOLiD instruments at its Heidelberg location (see In Sequence 9/29/2009).

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.